Improving Access to Hemophilia TherapiesPremiere Date: Monday, December 30, 2019
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, December 31, 2020
Note: Credit Is No Longer Available
|Guy A. Young, MD
Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Children's Hospital Los Angeles
Professor of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, CA
|Maya Bloomberg, MSN, APRN, FNP-BC
University of Miami Miller School of Medicine
Hemophilia Treatment Center
|James T. Kenney, RPh, MBA
President, JTKENNEY, LLC
President, Academy of Managed Care Pharmacy (AMCP)
While there are many new and emerging therapies for hemophilia, prior authorization (PA) levies a significant burden on hematologists and their team, often resulting in delayed access to appropriate treatments. However, these delays can often be avoided through improved documentation and enhanced provider-payer communication.
The second module in this CME Outfitters Snack series on prior authorization for hemophilia features expert faculty reviewing provider and payer insights into best practices for streamlining the prior authorization process to improve patient access to hemophilia therapies.
We encourage learners to complete all 3 CME Snacks in this series to receive a Certificate of Excellence in Prior Authorization.
At the end of this CE activity, participants should be able to:
- Implement strategies to streamline the PA and appeals process through improved documentation and enhanced provider-payer communication.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Describe strategies to streamline the PA and appeals process through improved documentation and enhanced provider-payer communication.
Supported by educational grants from CSL Behring LLC and Genentech.
Hematologists, physician assistants, nurse practitioners, nurses, pharmacists, medical assistants, and patients.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Learning Format:
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Young reports that he receives grants from Genentech, Inc. He is a consultant for Bayer Corporation; CSL Behring; Freeline; Genentech, Inc.; Grifols; Novo Nordisk; Roche; Spark Therapeutics, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Unique Pharmaceuticals Ltd.
Maya Bloomberg, MSN, APRN, FNP-BC, reports that she is an advisory board participant for Bayer Corporation; Genentech, Inc.; Global Blood Therapeutics Inc.; Octapharma Plasma Inc.; and Takeda Pharmaceuticals U.S.A., Inc.. She is on the speakers bureau for Alexion Pharmaceuticals, Inc.; Bayer Corporation; and Genentech, Inc.
James T. Kenney, RPh, MBA, has no disclosures to report.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Kavitha Ramachandran, PhD (planning committee) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).